Mayzent 2 mg (Siponimod TABLET) 2 MG

MAYZENT 2 MG tablets contain siponimod, a medication used to manage specific medical conditions. This oral treatment is designed to support therapeutic outcomes in approved indications.

Strength

2 MG

Manufacturer / TM Owner

NOVARTIS PHARMACEUTICALS CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

MAYZENT 2 MG tablets are primarily used for managing conditions related to immune system regulation. Siponimod, the active ingredient, is often prescribed for its potential to modulate immune responses. Patients may wonder, 'What is MAYZENT used for?' This medication is typically utilized in scenarios where immune system modulation is beneficial.

Side Effects

Common effects of MAYZENT 2 MG tablets may include changes in heart rate, blood pressure, and liver function. Some users might experience fatigue, headaches, or gastrointestinal discomfort. These effects can vary widely among individuals and are not exhaustive.

Precautions & Warnings

MAYZENT 2 MG tablets should be handled with care, especially by individuals with pre-existing heart or liver conditions. Regular monitoring and consultation with a healthcare provider are recommended. Always follow the prescribed guidelines for safe usage.

Avoid Interactions

MAYZENT 2 MG tablets may interact with certain medications, including those metabolized by the liver's CYP enzymes. Alcohol and other substances that affect liver function should be used cautiously. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

MAYZENT is used to manage conditions related to immune system regulation, often prescribed for its potential to modulate immune responses.

MAYZENT 2 MG tablets are taken orally, typically following a prescribed schedule. Always follow the instructions provided by your healthcare provider.

Common side effects may include changes in heart rate, blood pressure, fatigue, headaches, and gastrointestinal discomfort.

MAYZENT may interact with certain medications, especially those metabolized by the liver's CYP enzymes. Always consult your healthcare provider before combining medications.

Individuals with pre-existing heart or liver conditions should use MAYZENT with caution and under medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.